サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413471

無血清培地市場：製品タイプ、エンドユーザー、用途別-2024-2030年の世界予測

Serum-Free Media Market by Product (BHK Medium, CHO Media, HEK 293 Media), Type (Liquid Media, Semi-solid & Solid Media), End-User, Application - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
無血清培地市場：製品タイプ、エンドユーザー、用途別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

無血清培地市場規模は2023年に15億2,000万米ドルと推計され、2024年には16億8,000万米ドルに達し、CAGR 11.35%で2030年には32億3,000万米ドルに達すると予測されます。

無血清培地の世界市場

主な市場の統計
基準年[2023］ 15億2,000万米ドル
予測年[2024］ 16億8,000万米ドル
予測年 [2030] 32億3,000万米ドル
CAGR（%） 11.35%
無血清培地 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは無血清培地市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、無血清培地市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-無血清培地市場の市場規模および予測は？

2-無血清培地市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-無血清培地市場における技術動向と規制の枠組みは？

4-無血清培地市場における主要ベンダーの市場シェアは？

5-無血清培地市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • モノクローナル抗体、ワクチン、組換えタンパク質の生産の増加
      • 幹細胞調査に対する政府の投資と取り組みの増加
    • 抑制要因
      • 栄養素の制限と細胞増殖の低下
    • 機会
      • 無血清培地製品をカスタマイズするための学界とバイオテクノロジー企業の協力
      • バイオプロセス技術と分析ツールの進歩
    • 課題
      • 無血清培地の設計と最適化の複雑さ
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 無血清培地市場：製品別

  • BHKミディアム
  • CHOメディア
  • HEK 293メディア
  • 幹細胞培地
  • ベロミディアム

第7章 無血清培地市場：タイプ別

  • 液体媒体
  • 半固体および固体メディア

第8章 無血清培地市場：エンドユーザー別

  • 製薬およびバイオテクノロジー企業
  • 調査および学術機関

第9章 無血清培地市場：用途別

  • バイオ医薬品の生産
    • モノクローナル抗体
    • ワクチンの製造
  • 組織工学と再生医療

第10章 南北アメリカの無血清培地市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の無血清培地市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの無血清培地市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Ajinomoto Co., Inc.
    • ATZ Labz by Life Technologies（India）Pvt Ltd.
    • Becton, Dickinson and Company
    • Bio-Techne Corporation
    • Biowest
    • Celprogen Inc.
    • Corning Incorporated
    • Danahar Corporation
    • FUJIFILM Holdings Corporation
    • Fukoku Co., Ltd.
    • Gmep Incorporated
    • HiMedia Laboratories.
    • Jimi Biotech
    • Kyokuto Pharmaceutical Industrial Co., Ltd
    • Leinco Technologies, Inc.
    • Lonza Group
    • Merck KgaA
    • Myoridge Co. Ltd.
    • Nucleus Biologics
    • PAN-Biotech GmbH
    • R&D Systems, Inc.
    • REPROCELL Inc.
    • Sartorius AG
    • Shanghai BioEngine Sci-Tech Co, Ltd
    • Shanghai Excell Biological Technology Co., Ltd.
    • Sino Biological, Inc.
    • STEMCELL Technologies Canada Inc.
    • Thermo Fisher Scientific Inc.
    • TransGen Biotech Co., Ltd.
    • ZenBio, Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. SERUM-FREE MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. SERUM-FREE MEDIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SERUM-FREE MEDIA MARKET DYNAMICS
  • FIGURE 7. SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. SERUM-FREE MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. SERUM-FREE MEDIA MARKET SIZE, BY BHK MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SERUM-FREE MEDIA MARKET SIZE, BY CHO MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SERUM-FREE MEDIA MARKET SIZE, BY HEK 293 MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SERUM-FREE MEDIA MARKET SIZE, BY VERO MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. SERUM-FREE MEDIA MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. SERUM-FREE MEDIA MARKET SIZE, BY SEMI-SOLID & SOLID MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SERUM-FREE MEDIA MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 20. SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. SERUM-FREE MEDIA MARKET SIZE, BY VACCINES PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 232. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 233. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. SERUM-FREE MEDIA MARKET LICENSE & PRICING
目次
Product Code: MRR-7C31448F0BBF

[190 Pages Report] The Serum-Free Media Market size was estimated at USD 1.52 billion in 2023 and expected to reach USD 1.68 billion in 2024, at a CAGR 11.35% to reach USD 3.23 billion by 2030.

Global Serum-Free Media Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.52 billion
Estimated Year [2024] USD 1.68 billion
Forecast Year [2030] USD 3.23 billion
CAGR (%) 11.35%
Serum-Free Media Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Serum-Free Media Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Serum-Free Media Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Serum-Free Media Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., ATZ Labz by Life Technologies (India) Pvt Ltd., Becton, Dickinson and Company, Bio-Techne Corporation, Biowest, Celprogen Inc., Corning Incorporated, Danahar Corporation, FUJIFILM Holdings Corporation, Fukoku Co., Ltd., Gmep Incorporated, HiMedia Laboratories., Jimi Biotech, Kyokuto Pharmaceutical Industrial Co., Ltd, Leinco Technologies, Inc., Lonza Group, Merck KgaA, Myoridge Co. Ltd., Nucleus Biologics, PAN-Biotech GmbH, R&D Systems, Inc., REPROCELL Inc., Sartorius AG, Shanghai BioEngine Sci-Tech Co, Ltd, Shanghai Excell Biological Technology Co., Ltd., Sino Biological, Inc., STEMCELL Technologies Canada Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Serum-Free Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • BHK Medium
    • CHO Media
    • HEK 293 Media
    • Stem Cell Medium
    • Vero Medium
  • Type
    • Liquid Media
    • Semi-solid & Solid Media
  • End-User
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutes
  • Application
    • Biopharmaceutical Production
      • Monoclonal Antibodies
      • Vaccines Production
    • Tissue Engineering & Regenerative Medicine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Serum-Free Media Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Serum-Free Media Market?

3. What are the technology trends and regulatory frameworks in the Serum-Free Media Market?

4. What is the market share of the leading vendors in the Serum-Free Media Market?

5. Which modes and strategic moves are suitable for entering the Serum-Free Media Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Serum-Free Media Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing production of monoclonal antibodies, vaccines, and recombinant proteins
      • 5.1.1.2. Rising government investment and initiatives for stem cell research
    • 5.1.2. Restraints
      • 5.1.2.1. Nutrient limitations and reduced cell proliferation
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaboration among academia and biotech firms to customize serum-free media products
      • 5.1.3.2. Advancements in bioprocess technology and analytical tools
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity of designing and optimizing serum-free media
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Serum-Free Media Market, by Product

  • 6.1. Introduction
  • 6.2. BHK Medium
  • 6.3. CHO Media
  • 6.4. HEK 293 Media
  • 6.5. Stem Cell Medium
  • 6.6. Vero Medium

7. Serum-Free Media Market, by Type

  • 7.1. Introduction
  • 7.2. Liquid Media
  • 7.3. Semi-solid & Solid Media

8. Serum-Free Media Market, by End-User

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research & Academic Institutes

9. Serum-Free Media Market, by Application

  • 9.1. Introduction
  • 9.2. Biopharmaceutical Production
    • 9.3.1. Monoclonal Antibodies
    • 9.3.2. Vaccines Production
  • 9.3. Tissue Engineering & Regenerative Medicine

10. Americas Serum-Free Media Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Serum-Free Media Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Serum-Free Media Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Ajinomoto Co., Inc.
    • 14.1.2. ATZ Labz by Life Technologies (India) Pvt Ltd.
    • 14.1.3. Becton, Dickinson and Company
    • 14.1.4. Bio-Techne Corporation
    • 14.1.5. Biowest
    • 14.1.6. Celprogen Inc.
    • 14.1.7. Corning Incorporated
    • 14.1.8. Danahar Corporation
    • 14.1.9. FUJIFILM Holdings Corporation
    • 14.1.10. Fukoku Co., Ltd.
    • 14.1.11. Gmep Incorporated
    • 14.1.12. HiMedia Laboratories.
    • 14.1.13. Jimi Biotech
    • 14.1.14. Kyokuto Pharmaceutical Industrial Co., Ltd
    • 14.1.15. Leinco Technologies, Inc.
    • 14.1.16. Lonza Group
    • 14.1.17. Merck KgaA
    • 14.1.18. Myoridge Co. Ltd.
    • 14.1.19. Nucleus Biologics
    • 14.1.20. PAN-Biotech GmbH
    • 14.1.21. R&D Systems, Inc.
    • 14.1.22. REPROCELL Inc.
    • 14.1.23. Sartorius AG
    • 14.1.24. Shanghai BioEngine Sci-Tech Co, Ltd
    • 14.1.25. Shanghai Excell Biological Technology Co., Ltd.
    • 14.1.26. Sino Biological, Inc.
    • 14.1.27. STEMCELL Technologies Canada Inc.
    • 14.1.28. Thermo Fisher Scientific Inc.
    • 14.1.29. TransGen Biotech Co., Ltd.
    • 14.1.30. ZenBio, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing